Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Rose, L. M.
Right arrow Articles by Isenberg, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, L. M.
Right arrow Articles by Isenberg, D. A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The British Journal of Rheumatology, Vol 36, 158-163, Copyright © 1997 by British Society for Rheumatology

REVIEWS

Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review

LM Rose, DS Latchman and DA Isenberg
Department of Molecular Pathology, University College London Medical School.

There is increasing evidence to suggest that abnormalities in apoptosis may play a part in the pathogenesis of systemic lupus erythematosus (SLE). For example, there is now considerable evidence that bel-2 expression is enhanced in a proportion of peripheral T cells, but not in B cells, in SLE patients and correlates with overall disease activity regardless of the activity index employed. Further work is required to establish whether enhanced bel-2 expression by some T cells in SLE patients is related to their activation or intrinsically enhanced by genetic predisposition. Mutations in Fas result in a lymphoproliferative syndrome and may play a role in accelerating autoimmune disease. A report of three children with mutations in Fas has once again focused attention on this regulator of apoptosis. The relationships between inducers and inhibitors of apoptosis may differ in different cell types, and must be elucidated before the implications of observations made in lymphocytes from SLE patients can be fully understood.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ChestHome page
C.-Y. Ho, C.-K. Wong, F. W.-S. Ko, C. H.-S. Chan, A. S.-S. Ho, D. S.-C. Hui, and C. W.-K. Lam
Apoptosis and B-Cell Lymphoma-2 of Peripheral Blood T Lymphocytes and Soluble Fas in Patients With Allergic Asthma
Chest, November 1, 2002; 122(5): 1751 - 1758.
[Abstract] [Full Text] [PDF]

Home page
 LupusHome page
M. H Al-Maini, J. D Mountz, H. A Al-Mohri, E. M El-Ageb, B. M Al-Riyami, K. L G Svenson, T. Zhou, and E. R Richens
Serum levels of soluble Fas correlate with indices of organ damage in systemic lupus erythematosus
Lupus, February 1, 2000; 9(2): 132 - 139.
[Abstract] [PDF]

Home page
 Rheumatology (Oxford)Home page
M. L. Stoll and J. Gavalchin
Systemic lupus erythematosus--messages from experimental models
Rheumatology, January 1, 2000; 39(1): 18 - 27.
[Full Text] [PDF]

Home page
 LupusHome page
A Perniok, F Wedekind, M Herrmann, C Specker, and M Schneider
High levels of circulating early apoptic peripheral blood mononuclear cells in systemic lupus erythematosus
Lupus, February 1, 1998; 7(2): 113 - 118.
[Abstract] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.